Astal Laboratories Limited (BOM:512600)
India · Delayed Price · Currency is INR 69.54
-1.37 (-1.93%)
At close: Oct 1, 2026
Astal Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Interest and Dividend Income | - | - | - | - | - | 2.11 |
Total Interest Expense | 29.08 | 17.07 | 6.15 | 0.11 | - | - |
Net Interest Income | -29.08 | -17.07 | -6.15 | -0.11 | - | 2.11 |
Other Revenue | 3,250 | 2,503 | 643.56 | 236.61 | 36.07 | - |
Revenue Before Loan Losses | 3,221 | 2,486 | 637.41 | 236.5 | 36.07 | 2.11 |
| 3,221 | 2,486 | 637.41 | 236.5 | 36.07 | 2.11 | |
Revenue Growth | 325.99% | 290.08% | 169.51% | 555.71% | 1611.01% | 3.80% |
Salaries & Employee Benefits | 77.23 | 50.22 | 13.39 | 4.66 | - | 0.85 |
Cost of Services Provided | 2,803 | 2,207 | 484.21 | 215.42 | 35.67 | 0.11 |
Other Operating Expenses | 68.82 | 39.92 | 17.81 | 5.27 | - | 1.12 |
Total Operating Expenses | 2,968 | 2,309 | 517.63 | 225.64 | 35.75 | 2.23 |
Operating Income | 252.88 | 177.07 | 119.78 | 10.87 | 0.32 | -0.12 |
Currency Exchange Gain (Loss) | - | 0.23 | - | - | - | - |
EBT Excluding Unusual Items | 252.88 | 177.3 | 119.78 | 10.87 | 0.32 | -0.12 |
Pretax Income | 252.88 | 177.3 | 119.78 | 10.87 | 0.32 | -0.17 |
Income Tax Expense | 32.46 | 30.21 | 30.52 | 3.02 | 0.16 | 0 |
Net Income | 220.42 | 147.09 | 89.25 | 7.85 | 0.16 | -0.17 |
Net Income to Common | 220.42 | 147.09 | 89.25 | 7.85 | 0.16 | -0.17 |
Net Income Growth | 136.35% | 64.81% | 1037.42% | 4684.76% | - | - |
Shares Outstanding (Basic) | 39 | 17 | 10 | 5 | 4 | 4 |
Shares Outstanding (Diluted) | 42 | 19 | 11 | 5 | 4 | 4 |
Shares Change | 260.16% | 69.66% | 119.78% | 27.10% | - | - |
EPS (Basic) | 5.62 | 8.62 | 9.08 | 1.55 | 0.04 | -0.04 |
EPS (Diluted) | 5.26 | 7.81 | 8.04 | 1.55 | 0.04 | -0.04 |
EPS Growth | -34.38% | -2.86% | 417.52% | 3689.19% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -190.91 | -182.92 | -114.96 | -14.37 | -2.49 |
Free Cash Flow Per Share | - | -10.14 | -16.48 | -22.76 | -3.62 | -0.63 |
Operating Margin | 7.85% | 7.12% | 18.79% | 4.59% | 0.89% | -5.74% |
Profit Margin | 6.84% | 5.92% | 14.00% | 3.32% | 0.46% | -8.11% |
Free Cash Flow Margin | - | -7.68% | -28.70% | -48.61% | -39.83% | -118.03% |
Effective Tax Rate | 12.84% | 17.04% | 25.48% | 27.78% | 48.75% | - |
Revenue as Reported | 3,250 | 2,504 | 643.56 | 236.61 | - | 2.11 |